Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 21557880)

Published in Int J Neuropsychopharmacol on May 04, 2011

Authors

Martin Cohen1, Paul E Rasser1, Greg Peck2, Vaughan J Carr1, Philip B Ward3, Paul M Thompson4, Patrick Johnston5, Amanda Baker1, Ulrich Schall1

Author Affiliations

1: Schizophrenia Research Institute, Sydney, Australia.
2: Priority Centre for Brain & Mental Health Research, The University of Newcastle, Australia.
3: School of Psychiatry, University of New South Wales, Sydney, Australia.
4: Laboratory of Neuro Imaging, University of California Los Angeles, CA, USA.
5: Department of Psychology, University of York, UK.

Articles citing this

Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One (2013) 1.59

Effects of cannabis on impulsivity: a systematic review of neuroimaging findings. Curr Pharm Des (2014) 0.92

Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex. BMC Neurosci (2012) 0.88

Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. Eur Arch Psychiatry Clin Neurosci (2012) 0.88

A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis. Neurosci Biobehav Rev (2016) 0.87

Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies. Curr Pharm Des (2012) 0.84

The endocannabinoid system, cannabinoids, and pain. Rambam Maimonides Med J (2013) 0.81

Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis. BMC Psychiatry (2015) 0.80

An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use. Front Psychiatry (2012) 0.77

Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders. J Psychiatry Neurosci (2015) 0.77

MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse. Psychol Med (2012) 0.77

The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability. Front Psychiatry (2014) 0.77

Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling. Exp Brain Res (2012) 0.76

The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study. Schizophr Res Treatment (2013) 0.76

Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity. PLoS One (2014) 0.75